Limited Competition: Comprehensive Alcohol-HIV/AIDS Research Center (P60)
The summary for the Limited Competition: Comprehensive Alcohol-HIV/AIDS Research Center (P60) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Limited Competition: Comprehensive Alcohol-HIV/AIDS Research Center (P60): This Funding Opportunity Announcement (FOA) is limited to renewal applications for a research center grant to conduct cross-cutting research on alcohol and HIV/AIDS. Through this FOA, NIAAA seeks to encourage research that can be translated into interventions in order to reduce infection and transmission of HIV. The FY2013 Trans-NIH Plan For HIV-Related Research (http://www.oar.nih.gov/strategicplan/fy2013/index.asp) describes the goals of highest priority. This limited competition FOA solicits applications from current awardees of the Alcohol and HIV/AIDS Comprehensive Research Center
Federal Grant Title: | Limited Competition: Comprehensive Alcohol-HIV/AIDS Research Center (P60) |
Federal Agency Name: | National Institutes of Health |
Grant Categories: | Health |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | RFA-AA-14-003 |
Type of Funding: | Grant |
CFDA Numbers: | 93.273 |
CFDA Descriptions: | Alcohol Research Programs |
Current Application Deadline: | Apr 15, 2014 |
Original Application Deadline: | Apr 15, 2014 |
Posted Date: | Dec 12, 2013 |
Creation Date: | Dec 12, 2013 |
Archive Date: | May 16, 2014 |
Total Program Funding: | $2,000,000 |
Maximum Federal Grant Award: | $2,000,000 |
Minimum Federal Grant Award: | none |
Expected Number of Awards: | 1 |
Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Additional Information on Eligibility
- Other Eligible Applicants include the following:
Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
- Link to Full Grant Announcement
- http://grants.nih.gov/grants/guide/rfa-files/RFA-AA-14-003.html
- Grant Announcement Contact
- NIH OER Webmaster
[email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
National Institutes of Health 301-496-3405 - Similar Government Grants
- • Limited Competition: Alcohol-associated Hepatitis Clinical Network Integrated Treatment C...
- • Limited Competition: Alcohol-associated Hepatitis Clinical Network Integrated Treatment C...
- • Model Continuums of Care Initiative (MCCI) to Advance Health Equity and End Health Dispari...
- • Limited Competition: Collaborative Study on the Genetics of Alcoholism (COGA) (U10 Clinica...
- • Pilot and Feasibility Studies in Preparation for Substance Use Prevention Trials (R34 Clin...
- • Mechanisms of Alcoholic Pancreatitis
- • Alcohol Abuse and Hiv/Aids in Resource-Poor Societies
- • Mechanisms of Alcohol-Induced Tissue Injury
- More Grants from the National Institutes of Health
- • Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Tri...
- • Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education E...
- • HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggabl...
- • Optimizing Behavioral Sleep Interventions for Adolescents and Young Adults (R34 Clinical T...
- • Global Infectious Disease Research Training Program (D43 Clinical Trial Optional)